Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Amneal Pharmaceuticals Inc
(NY:
AMRX
)
4.850
USD
-0.120 (-2.41%)
Official Closing Price
Updated: 7:36 PM EST, Jan 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Amneal Pharmaceuticals Inc
< Previous
1
2
3
Next >
Amneal to Acquire Substantially All of Kashiv Specialty Pharmaceuticals
January 12, 2021
Amneal Pharmaceuticals, Inc. (the “Company”) (NYSE:AMRX) and Kashiv BioSciences LLC (“Kashiv”) today announced they have entered into a definitive agreement under which Amneal Pharmaceuticals LLC...
From
Business Wire News Releases
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA
January 08, 2021
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) announced that it has received approval of an additional strength of 500 mg to its Abbreviated New Drug Application (ANDA), from...
From
Business Wire News Releases
Amneal to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that Chirag Patel, Amneal’s Co-Chief Executive Officer and President, will present at the 39th Annual J.P. Morgan Healthcare...
From
Business Wire News Releases
Recent Challenges Demand Innovative Approaches to Surface Disinfections
December 17, 2020
- FinancialBuzz.com News Commentary
From
PR Newswire
Amneal Receives Abbreviated New Drug Application Approval for Acyclovir Cream, 5%
November 11, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) today announced that it has received approval for its Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA) for...
From
Business Wire News Releases
Amneal Reports Third Quarter 2020 Financial Results
November 06, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the third quarter ended September 30, 2020.
From
Business Wire News Releases
Amneal to Report Third Quarter 2020 Results on November 6, 2020
October 15, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2020 financial results on Friday, November 6, 2020, prior to market open. The Company will host...
From
Business Wire News Releases
Spectrum Brands Holdings Appoints Gautam Patel and Anne S. Ward to the Board of Directors
October 13, 2020
Spectrum Brands Holdings Appoints Gautam Patel and Anne S. Ward to the Board of Directors
From
Business Wire News Releases
Company Profile for Amneal Pharmaceuticals
October 08, 2020
Amneal Pharmaceuticals, Inc. (NYSE:AMRX), headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and...
Tags
Amneal Pharmaceuticals, Inc.
From
Business Wire News Releases
Amneal & PL Developments Launch Store Brand Program of Over-the-Counter (“OTC”) Diclofenac Sodium Topical Gel, 1%
October 08, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand equivalent Voltaren® Arthritis Pain Gel...
From
Business Wire News Releases
Amneal to Virtually Participate at the Morgan Stanley Global Healthcare Conference
September 01, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that members of management will participate at the Morgan Stanley Global Healthcare Conference held on September 15, 2020. The...
From
Business Wire News Releases
Amneal Receives Abbreviated New Drug Application Approval for Lidocaine Patch, 5%
August 25, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration...
From
Business Wire News Releases
Wishbone Medical Appoints Jeff George to Board of Directors
August 12, 2020
From
GlobeNewswire News Releases
Amneal Reports Second Quarter 2020 Financial Results
August 06, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the second quarter ended June 30, 2020.
From
Business Wire News Releases
NetworkNewsBreaks – Eastman Kodak Co. (NASDAQ: KODK) Stock Heads Skyward after Company Receives First-of-Its-Kind Government Loan
July 29, 2020
From
InvestorBrandNetwork
Cosette Pharmaceuticals Appoints Seasoned Industry Executive Apurva Saraf as President and Chief Executive Officer
July 14, 2020
From
GlobeNewswire News Releases
Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
July 13, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Unum Therapeutics, Nokia, Amneal Pharmaceuticals, Aytu Bioscience, or Niu Technologies?
July 10, 2020
InvestorsObserver issues critical PriceWatch Alerts for UMRX, NOK, AMRX, AYTU, and NIU.
From
PR Newswire
Amneal Launches Generic Fluphenazine Following ANDA Approval by FDA
July 10, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration...
From
Business Wire News Releases
Amneal to Report Second Quarter 2020 Results on August 6, 2020
July 08, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, prior to market open. The Company will...
From
Business Wire News Releases
Amneal Reports First Quarter 2020 Financial Results
May 11, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the first quarter ended March 31, 2020.
From
Business Wire News Releases
Amneal to Report First Quarter 2020 Results on May 11, 2020
April 24, 2020
Amneal to Report First Quarter 2020 Results on May 11, 2020
From
Business Wire News Releases
Amneal Launches Generic Butrans® Following ANDA Approval by FDA
April 16, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration...
From
Business Wire News Releases
Eagle Pharmaceuticals Announces Laboratory Test Results Demonstrating In Vitro Antiviral Activity of RYANODEX® (dantrolene sodium) Against Coronavirus SARS-CoV-2
April 16, 2020
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”), a New Jersey-based pharmaceutical company, today announced that its product RYANODEX® (dantrolene sodium) for injectable suspension inhibited the...
From
Business Wire News Releases
Amneal Pharmaceuticals Moving to a Virtual Meeting Format for 2020 Annual Meeting of Stockholders
April 15, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) will be a virtual meeting instead of an...
From
Business Wire News Releases
State of Texas and Senator Bryan Hughes Secure a Donation of Hydroxychloroquine Sulfate from Amneal Pharmaceuticals for Texas Patients
March 26, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”), one of the largest U.S.-based generics manufacturers, and the State of Texas today announced that they are responding to the...
From
Business Wire News Releases
Thinking about buying stock in Amneal Pharmaceuticals, B2Gold, Chesapeake Energy Corp, Hepion Pharmaceuticals, or Waitr?
March 23, 2020
InvestorsObserver issues critical PriceWatch Alerts for AMRX, BTG, CHK, HEPA, and WTRH.
From
PR Newswire
Amneal Accelerates Distribution and Production of Hydroxychloroquine Sulfate to Meet Potential Needs of COVID-19 Patients Nationwide
March 20, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”), one of the largest U.S.-based generics manufacturers, today announced that it is responding to the national COVID-19 health...
From
Business Wire News Releases
Amneal Pharmaceuticals Appoints Tasos Konidaris as Senior Vice President, Chief Financial Officer
March 11, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has appointed Tasos Konidaris as Senior Vice President, Chief Financial Officer, effective March 12, 2020. Mr....
From
Business Wire News Releases
Amneal Reports Fourth Quarter and Full Year 2019 Financial Results
February 26, 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the fourth quarter and full year ended December 31, 2019.
From
Business Wire News Releases
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.